InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: None

Thursday, 02/22/2007 11:04:57 AM

Thursday, February 22, 2007 11:04:57 AM

Post# of 3562
Teva Gets Approval on Generic Aciphex
Thursday February 22, 10:59 am ET
Teva Pharmaceutical Industries Receives Final FDA Approval on Generic Aciphex

NEW YORK (AP) -- Generic drug developer Teva Pharmaceutical Industries Ltd. said Thursday the Food and Drug Administration approved its generic version of Eisai Co.'s heartburn drug Aciphex.

Israel-based Teva is involved in a patent lawsuit with Eisai over the delayed-release, 20-milligram tablets. A trial in the U.S. District Court for the Southern District of New York is scheduled for March 5.

Shares of Teva fell 43 cents to $37.92 on the Nasdaq Stock Market in morning trading.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News